Sidley Austin is proud to sponsor the 2013 New Paradigms Conference, featuring key individuals from biotech, pharma and the investment community to advance R&D through alternative sources of funding, non-traditional partnering strategies and regulatory insights. Coleen Klasmeier, a partner and Global Coordinator in Sidley’s Food, Drug & Medical Device Regulatory Practice in Washington, D.C., will participate in a panel discussion, “A Disruptive Approach to Fundamental Reform.”
Panel Discussion
“A Disruptive Approach to Fundamental Reform”
January 8, 2013, 3:45 pm
Moderated by: Peter Milner, MD, CEO, Heart Metabolics and Co-Founder, CVT, ARYx, Armetheon and Optivia
- Changing approval standards
- Addressing the misconception of reform and the effect on the FDA
- Are we taking the right approach in amending the statute every five years?
Panelists:
David Gollaher, PhD, President & CEO, California Healthcare Institute
Coleen Klasmeier, Global Coordinator, Food, Drug & Medical Device Regulatory Practice, Sidley Austin LLP
Chris Meda , Vice Chair, Women in Bio (WIB) San Francisco Chapter